Skip to main navigation
logo
Logo

Site - Top Nav

  • About Iveric
  • Our Commitment
  • Why Iveric?
  • Clinical Programs
  • Investor Relations
  • Contact Us

Site - IR Nav

  • Investor Relations
  • News
  • Events & Presentations
  • Corporate Governance
    • Leadership
    • Board of Directors
    • Committee Composition
    • Contact the Board
  • Financial Information
    • SEC Filings
    • Annual Reports
    • Quarterly Results
    • Key Ratios
  • IRS Form 8937
  • Stock Information
    • Historic Stock Lookup
    • Investment Calculator
    • Analyst Coverage
  • Investor FAQs
  • Derivative Settlement
  • Contact Us

Press Releases

11.02.2022
Iveric Bio Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
10.27.2022
Iveric Bio to Report Third Quarter 2022 Financial Results and Host Conference Call on Thursday, November 3, 2022
10.04.2022
Iveric Bio Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
09.27.2022
Iveric Bio to Present Top-line Results for Avacincaptad Pegol from Phase 3 GATHER2 Clinical Trial in Geographic Atrophy at AAO 2022 Annual Meeting
09.07.2022
Iveric Bio to Present at Upcoming Investor Conferences
09.06.2022
Iveric Bio Announces Positive Topline Data from Zimura® GATHER2 Phase 3 Clinical Trial in Geographic Atrophy
09.02.2022
Iveric Bio Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
08.10.2022
Iveric Bio to Participate in the H.C. Wainwright 2nd Annual Ophthalmology Virtual Conference
08.03.2022
Iveric Bio to Present at the Wedbush PacGrow Healthcare Conference 2022
08.02.2022
Iveric Bio Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Pagination

  • First page « first
  • Previous page ‹ previous
  • Page 1
  • Current page 2
  • Page 3
  • Page 4
  • Page 5
  • Page 6
  • Page 7
  • Page 8
  • Page 9
  • …
  • Next page next ›
  • Last page last »

Site - Shareholder Tools

Printed Materials
Printed Materials
Email Alerts
Email Alerts
Downloads
Downloads
RSS Feeds
RSS Feeds
Print
Print
Share This
Share This
Twitter
Twitter

Site - Footer Nav

  • Contact Us
  • Careers
  • Expanded Access
  • Privacy Policy
  • Sitemap